Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: Results of a feasibility pilot trial

Journal of Endovascular Therapy

Volumn 14, Issue 4, 2007, Pages 520-527

  Allie, David E ^a   Lirtzman, Mitchell D ^a   Wyatt, Charles H ^a   Keller, V Antoine ^a   Mitran, Elena V ^a   Hebert, Chris J ^a   Patlola, Raghotham ^a   Veerina, Kalyan K ^a   Walker, Craig M ^a  

^a Cardiovascular Institute of the South   (United States)

Author keywords

Abdominal aortic aneurysm; Contrast induced nephropathy; Endovascular repair; Fenoldopam; Renal insufficiency; Targeted renal therapy

Indexed keywords

CONTRAST MEDIUM; CREATININE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; FENOLDOPAM MESILATE; HEPARIN; DOPAMINE RECEPTOR STIMULATING AGENT; VASODILATOR AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEVICE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD VESSEL TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; EQUIPMENT DESIGN; FEASIBILITY STUDY; INSTRUMENTATION; INTERVENTIONAL RADIOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY FAILURE; MIDDLE AGED; PILOT STUDY; RADIOGRAPHY; RENAL ARTERY; TIME; TREATMENT OUTCOME;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONTRAST MEDIA; DOPAMINE AGONISTS; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; FENOLDOPAM; HUMANS; INFUSIONS, INTRA-ARTERIAL; KIDNEY DISEASES; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIOGRAPHY, INTERVENTIONAL; RENAL ARTERY; RENAL INSUFFICIENCY; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34848889028     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2007)14[520:TRTACN]2.0.CO;2     Document Type: Article

References (31)

1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5:491-499.
2. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563-570.
3. McAlister FA, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109:1004-1009.
4. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805.
5. Gottlieb SS, Abraham W, Butler J. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8:136-141.
6. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113:1063-1070.
7. Hillis GS, Croal BL, Buchan KG, et al. Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. Circulation. 2006;113:1056-1062.
8. Azizzadeh A, Sanchez LA, Miller CC, et al. Glomerular filtration rate is a predictor of mortality after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2006;43:14-18.
9. Powell RJ, Roddy SP, Meier GH, et al. Effect of renal insufficiency on outcome following infrarenal aortic surgery. Am J Surg. 1997;174:126-130.
10. Matsumura JS, Brewster DC, Makaroun MS, et al. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg. 2003;37:262-271.
11. Johnston KW. Multicenter prospective study of nonruptured abdominal aortic aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg. 1989;9:437-447.
12. Miller D, Meyers B. Pathophysiology and prevention of renal failure associated with thoracoabdominal or abdominal aortic surgery. J Vasc Surg. 1987;5:518-23.
13. Greenberg RK, Chuter TA, Sternbergh WC, et al. Zenith AAA endovascular graft: intermediate-term results of the US multicenter trial. J Vasc Surg. 2004;39:1209-1218.
14. Greenberg RK, Chuter TA, Lawrence-Brown M, et al. Analysis of renal function after aneurysm repair with a device using suprarenal fixation (Zenith AAA Endovascular Graft) in contrast to open surgical repair. J Vasc Surg. 2004;39:1219-1228.
15. Forbes TL, Harding GE, Lawlor DK, et al. Comparison of renal function after endovascular aneurysm repair with different transrenally fixated endografts. J Vasc Surg. 2006;44:938-942.
16. Carpenter JP, Fairman RM, Barker CF, et al. Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc Surg. 2001;9:559-564.
17. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-2291.
18. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
19. Heyman SN, Clark BA, Kaiser N, et al. Radio-contrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol. 1992;3:58-65.
20. Arakawa K, Suzuki H, Naitoh M, et al. Role of adenosine in the renal responses to contrast medium. Kidney Int. 1996;49:1199-1206.
21. Teirstein PS, Price MJ, Mathur VS, et al. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. Am J Cardiol. 2006;97:1076-1081.
22. Stone GW, Mehran R. Pharmacologic prevention of contrast-induced nephropathy. J Invasive Cardiol. 2005;17:9C-14C.
23. Bush RL, Johnson ML, Hedayati N, et al. Performance of endovascular aortic aneurysm repair in high-risk patients: results from the Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2007;45:227-235.
24. EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet. 2005;365:2187-2192.
25. Walsh SR, Tang T, Gaunt ME, et al. Contrast-induced nephropathy. J Endovasc Ther. 2007;14:92-100.
26. Barrett BJ, Parfrey PS. Preventing neuropathy induced by contrast medium. N Eng J Med. 2006;354:379-386.
27. Moore NN, Lapsley M, Norden AG, et al. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. J Endovasc Ther. 2006;13:660-666.
28. Allie DE, Hebert CJ, Walker CM. Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue." J Invasive Cardiol. 2007;19:E27-E30.
29. Allie DE. Clinical use of targeted renal therapy in the "real world": abdominal aortic aneurysm, coronary artery bypass graft, percutaneous transluminal angioplasty and beyond! Vasc Dis Manage. 2006;3(suppl):9-11.
30. Ranucci M, Soro G, Barzaghi N, et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg. 2004;78:1332-1338.
31. Huyng TT, van Eps RG, et al. Azizzadeh A, et al. Glomerular filtration rate is superior to serum creatinine for predication of mortality following thoracoabdominal aortic surgery. J Vasc Surg. 2005;42:206-212.